Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer [Phase 3]
Phase III trial OVATURE comparing weekly carboplatin with and without phenoxodiol in platinum-resistant recurrent epithelial ovarian cancer …
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
A completed Phase 1/Phase 2 study evaluating phenoxodiol in combination with cisplatin or paclitaxel for recurrent ovarian epithelial, fallo…
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: A Phase II Study of Akt Inhibitor MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]
Phase II trial results for MK-2206, an Akt inhibitor, in recurrent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer …
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: UCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer [Phase 1]
Phase 1 trial evaluating UCN-01 in combination with topotecan in patients with recurrent ovarian epithelial cancer, fallopian tube cancer, o…
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Phase II ABT-888 With Cyclophosphamide [Phase 2]
Phase II trial evaluating veliparib (ABT-888) in combination with cyclophosphamide across ovarian and related gynecologic cancers; results w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies [Phase 2]
Phase 2 clinical trial evaluating sequential angiogenic blockade for recurrent Mullerian malignancies, completed with results posted in 2016…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers [Phase 2]
Phase 2 study evaluating MM-121 (seribantumab) in combination with paclitaxel for platinum-resistant/refractory advanced ovarian, fallopian …
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: Minimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility Study [Phase 2]
Clinical trial update indicates the Phase 2 feasibility study of minimally invasive interval debulking surgery for stage IV ovarian carcinom…
-
CLINICAL_TRIALS trial_result · 2016-04-05Clinical Trial Update: Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane [Phase 3]
A Phase 3 trial comparing chemotherapy versus hormonal treatment in platinum-resistant ovarian cancer (including peritoneal and fallopian tu…
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCT [Phase 2]
A Phase II randomized trial comparing local modulated electro-hyperthermia (mEHT) plus Traditional Chinese Medicine to intraperitoneal chemo…
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma [Phase 1]
Phase 1 trial of a cancer vaccine therapy with GM-CSF in patients with acute myeloid leukemia, myelodysplastic syndromes, non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission [Phase 2]
A Phase 2 trial of sorafenib for ovarian epithelial cancer, Fallopian tube cancer, and primary peritoneal cancer in patients in their second…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy [Phase 1, Phase 2]
This completed Phase 1/2 trial evaluates hyperthermic intraperitoneal chemotherapy (HIPEC) as first-line therapy for patients with Stage III…
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 1]
This Phase 1 trial update investigates abdominal radiation plus docetaxel for recurrent or persistent advanced ovarian, fallopian tube, or p…
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084) [Phase 1]
This is a completed Phase 1 clinical trial update for SCH-58500 in patients with fallopian tube cancer, ovarian cancer, or primary peritonea…
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma [Phase 1]
This Phase 1 trial assesses dose escalation of cisplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC) after surgery in patients w…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial evaluating a combination of intravenous and intraperitoneal paclitaxel, intraperitoneal cisplatin, and intravenous be…
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer [Phase 1]
A Phase 1 clinical trial evaluating the combination of birinapant and conatumumab in relapsed ovarian and related cancers has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating combination chemotherapy in patients with ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal c…
-
CLINICAL_TRIALS trial_result · 2015-11-09Clinical Trial Update: AZD2171 in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 2]
This update reports results from a Phase 2 study of cediranib (AZD2171) in patients with recurrent ovarian, fallopian tube, or primary perit…
-
CLINICAL_TRIALS trial_result · 2015-10-26Clinical Trial Update: S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer [Phase 3]
A Phase 3 study (SWOG S0200) comparing carboplatin with or without Doxil in recurrent ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer [Phase 1]
Phase 1 study of trebananib (AMG 386) in combination with paclitaxel and carboplatin for ovarian cancer, fallopian tube cancer, and primary …
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer [NA]
This completed clinical trial from Ohio State University Comprehensive Cancer Center evaluated whether stress-reduction interventions can im…
-
CLINICAL_TRIALS trial_result · 2015-08-25Clinical Trial Update: Panitumumab and Gemcitabine in Relapsed Ovarian Cancer [Phase 2]
Phase 2 trial evaluating the combination of panitumumab and gemcitabine in relapsed ovarian, fallopian tube, and primary peritoneal cancers …
-
CLINICAL_TRIALS trial_result · 2015-08-05Clinical Trial Update: Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 3]
This Phase 3 trial evaluated chemotherapy plus surgery for patients with stage III or IV ovarian, fallopian tube, or primary peritoneal canc…